Kurome Therapeutics, a pre-clinical stage company dedicated to developing novel therapies that target adaptive resistance mechanisms in cancer cells while inhibiting critical disease modifying genes, has closed a $15 million Series A financing round. Medicxi and Affinity Asset Advisors co-led the funding round with participation from founding investor CincyTech, and other existing seed investors. To read more, click here. The company’s technology is based on research at Cincinnati Children’s Hospital Medical Center in collaboration with the National Institutes of Health’s National Center for Advancing Translational Sciences. To read more, click here.
“Over the past two decades, there has been little innovation in health insurance. Employers need a better health insurance option and cost savings. They need a health benefit that gives their employees first-dollar coverage, clear choices and cost certainty. That is exactly what Bind delivers,” said Shawn Wagoner, Bind Chief Revenue Officer. Ohio ranked 13th in the country for highest healthcare spending per person by state, according to a 2018 Health Care Cost Institute report. Ohioans who get their health insurance through work spent an average of $6,181 per person, higher than the national average of $5,892.
Bind personalized health plans allow people to see treatment options and compare costs in advance of care, flex coverage as needs change and eliminate the fuzzy math caused by deductibles and coinsurance. Bind has shown that when you give people tools to easily make informed decisions, they do. Bind Benefits, Inc. announced that its personalized health plan will be offered on a fully insured basis to Ohio employers with more than 50 employees. With Bind, employers have the opportunity to lower health care costs while giving their employees a rich benefit with a wide network and more health care decision-making power.
To read more, click here. Source Porter previously worked with Syneos Health where she rebuilt regional CRO leadership and infrastructure across 13 countries.
Elligo also added COO Miranda Mann Porter to its leadership team. Porter is an experienced global leader with a diverse background in therapeutics (CNS), operational execution of clinical development programs and Phase I-IV trials, post-marketing medical affairs services, and healthcare delivery. Elligo Health Research has acquired Root Health, an AI virtual assistant for clinical research. The move is intended to support Elligo’s integrated research organization to improve the efficiency of clinical research and is designed to support easy access for faster enrollment and accelerated trials overall.
The News Highlights
- StartUPDATES: New Health Startup Developments
- Check the latest Health news updates and information about health.
For Latest News Follow us on Google News
- Show all
- Trending News
- Popular By week